PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 26.925
EU - Europa 22.678
AS - Asia 15.621
SA - Sud America 1.851
AF - Africa 312
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 19
Totale 67.449
Nazione #
US - Stati Uniti d'America 26.573
RU - Federazione Russa 6.975
SG - Singapore 6.669
GB - Regno Unito 6.270
CN - Cina 4.898
IT - Italia 2.073
BR - Brasile 1.521
SE - Svezia 1.516
DE - Germania 1.312
FR - Francia 1.258
HK - Hong Kong 1.152
VN - Vietnam 1.127
FI - Finlandia 1.123
IE - Irlanda 1.113
KR - Corea 519
UA - Ucraina 419
IN - India 219
JP - Giappone 192
CA - Canada 182
TR - Turchia 160
BE - Belgio 121
AR - Argentina 120
BD - Bangladesh 114
MX - Messico 104
NL - Olanda 93
NG - Nigeria 84
ID - Indonesia 81
PL - Polonia 78
IQ - Iraq 77
ZA - Sudafrica 74
ES - Italia 69
IR - Iran 61
PK - Pakistan 58
EC - Ecuador 54
UZ - Uzbekistan 39
VE - Venezuela 37
AU - Australia 33
MA - Marocco 33
CO - Colombia 31
CZ - Repubblica Ceca 30
PY - Paraguay 27
RO - Romania 27
CH - Svizzera 26
LT - Lituania 26
AT - Austria 25
AE - Emirati Arabi Uniti 23
AZ - Azerbaigian 21
CL - Cile 20
EG - Egitto 20
SA - Arabia Saudita 20
KE - Kenya 19
PE - Perù 19
NP - Nepal 18
PH - Filippine 18
IL - Israele 17
MY - Malesia 17
BG - Bulgaria 16
KG - Kirghizistan 14
TN - Tunisia 14
BO - Bolivia 13
DZ - Algeria 13
EU - Europa 13
JO - Giordania 13
AL - Albania 12
PA - Panama 12
LB - Libano 11
KZ - Kazakistan 10
RS - Serbia 10
CR - Costa Rica 9
LV - Lettonia 9
NZ - Nuova Zelanda 9
SN - Senegal 9
HU - Ungheria 8
PS - Palestinian Territory 8
PT - Portogallo 8
TT - Trinidad e Tobago 8
DK - Danimarca 7
HR - Croazia 7
JM - Giamaica 7
OM - Oman 7
SY - Repubblica araba siriana 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
TG - Togo 6
TH - Thailandia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BH - Bahrain 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
GA - Gabon 5
HN - Honduras 5
KW - Kuwait 5
MD - Moldavia 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
BJ - Benin 4
CY - Cipro 4
EE - Estonia 4
Totale 67.355
Città #
Southend 5.299
Jacksonville 3.687
Singapore 3.676
Ashburn 2.934
Chandler 2.484
Dallas 2.377
Moscow 2.162
Woodbridge 2.116
San Jose 1.888
Ann Arbor 1.394
Houston 1.197
Hong Kong 1.131
Dublin 1.111
The Dalles 748
Verona 655
Beijing 627
Wilmington 472
Lawrence 445
Princeton 445
Jinan 444
Los Angeles 431
Nanjing 413
New York 391
Ho Chi Minh City 368
Shenyang 353
Buffalo 274
Hanoi 264
Hebei 229
Helsinki 211
Tianjin 210
Boardman 201
Sindelfingen 185
Munich 179
Columbus 156
Changsha 153
Zhengzhou 153
São Paulo 150
Milan 149
Nanchang 142
Haikou 131
Hangzhou 126
Council Bluffs 124
Ningbo 124
Santa Clara 123
Brussels 113
Taizhou 113
Tokyo 111
Jiaxing 107
Orem 102
Guangzhou 99
Seattle 96
Philadelphia 88
Redondo Beach 86
Taiyuan 86
Washington 81
Turku 79
Falls Church 75
Seoul 74
Frankfurt am Main 72
London 71
Norwalk 71
Abuja 70
Lancaster 67
Rome 65
San Francisco 65
Chennai 63
Montreal 62
Warsaw 60
Toronto 58
Dearborn 57
Fuzhou 57
Auburn Hills 56
Brooklyn 56
Chicago 53
Denver 51
Düsseldorf 51
Stockholm 51
Redmond 49
Rio de Janeiro 48
Fairfield 47
Manchester 47
Da Nang 46
Lanzhou 46
Amsterdam 44
Jakarta 44
Haiphong 43
Boston 41
Atlanta 40
Johannesburg 37
Mumbai 34
Phoenix 34
Tashkent 33
Paris 31
Dong Ket 30
Biên Hòa 29
Brasília 29
Cambridge 29
Shanghai 29
Bologna 28
Leawood 28
Totale 43.864
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 470
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 439
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 436
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 322
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 311
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 305
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 293
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 292
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 292
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 277
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 269
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 266
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 264
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 263
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 260
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 258
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 256
A rapid immunostaining method for frozen sections 252
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 248
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 247
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 244
Acute leukemia and pregnancy. Case report 243
A study of the crosstalk between CD30 and CXCR4 243
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 243
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 241
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 240
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 239
Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus 238
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 238
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 237
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 236
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 235
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 235
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 234
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 233
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 232
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 230
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 229
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 228
Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model 226
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 224
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 224
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 223
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 223
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
BCR-signaling profiles associated with prognosis and progression in B-CLL 221
Blastic OKT6-positive proliferation preceding malignant histiocytosis 219
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 219
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 219
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 218
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 216
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 216
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 215
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 214
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 214
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 213
BCR-signaling profiles associated with prognosis and progression in B-CLL 211
Bone marrow-, but not thymus-, derived stromal cells inhibit spontaneous apoptosis and induce proliferation in blasts of T-lineage ALL 209
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 209
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 208
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 208
[Haemolytic anaemia associated with acquired deficiency of erythrocyte glutathione peroxidase: use of sodium selenite to correct the enzyme defect (author's transl)] 207
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 207
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 206
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 206
Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial 205
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 204
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 203
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 202
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 201
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 201
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 201
[Immunology of the lymphatic follicle] 200
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 200
An unusual case of acute leukaemia 199
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 199
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 198
Natural killer cell function and lymphoid subpopulations in acute non-lymphoblastic leukaemia in complete remission 198
G-CSF-stimulated neutrophils are a prominent source of functional B-lymphocyte stimulator (BLyS) 197
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 196
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 196
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 196
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 196
Soluble interleukin-2 receptors in the serum of patients with Hodgkin's disease 195
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 195
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 194
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 192
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 191
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 191
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 191
Activated T cells with immunoregulatory functions at different sites of involvement in sarcoidosis. Phenotypic and functional evaluations 190
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 190
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 190
Biological prognostic factors in indolent lymphoma 188
Computer-based drug management in a bone marrow transplant unit: a suitable tool for multiple prescriptions even in critical conditions 188
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 187
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 187
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 187
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 187
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 187
Totale 22.938
Categoria #
all - tutte 197.181
article - articoli 141.302
book - libri 0
conference - conferenze 53.331
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.548
Totale 394.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021943 0 0 0 0 0 0 0 0 0 40 700 203
2021/20223.812 331 1.091 44 264 212 118 76 203 135 142 389 807
2022/20237.250 582 583 658 1.295 744 1.768 59 473 771 42 181 94
2023/20243.451 174 297 300 391 356 501 188 431 18 124 409 262
2024/20258.611 600 595 220 1.458 472 279 318 383 1.323 475 706 1.782
2025/202623.259 1.866 1.831 1.905 3.535 5.636 1.730 2.436 1.257 1.776 1.287 0 0
Totale 67.764